Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | PEP08 |
| Synonyms | |
| Therapy Description |
Limited information is currently available on PEP08, a putative PRMT5 inhibitor (Sep 2025). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| PEP08 | PEP-08|PEP 08 | PRMT5 Inhibitor 21 | Limited information is currently available on PEP08, a putative PRMT5 inhibitor (Sep 2025). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT06973863 | Phase I | PEP08 | A Study of PEP08 in Patients With MTAP-Del Advanced or Metastatic Solid Tumors | Not yet recruiting | AUS | 0 |